Intellectual Property

  • January 31, 2024

    Canada, U.K. pursue innovation ties relating to AI and other scientific initiatives

    Minister of Innovation, Science and Industry François-Philippe Champagne has signed two memorandums of understanding (MOU) with the U.K.’s Secretary of State for Science, Innovation and Technology Michelle Donelan during her visit to Canada. The MOUs address the pursuit of international science and research collaboration.

  • January 31, 2024

    Seismotech IP Holdings Inc. v. Apple Canada: Norwich order not granted

    With the growth of the Internet, actionable behaviour is increasingly occurring online and is often being committed by anonymous actors.

  • January 30, 2024

    Seven new partners for Aird & Berlis

    Aird & Berlis has announced that Dillon Collett, Sean Green, Cathy Jares, Naomi Mares, Felix Ng, Alexandra Raponi and Josh Suttner have become partners, according to a statement from the firm.

  • January 30, 2024

    French Language Charter draft regulations provides more clarity but questions remain

    An eagerly awaited draft regulation intended to yield guidance on amendments introduced by Bill 96 to the Charter of the French Language sheds light on certain areas but raises additional questions, is more restrictive, has more onerous requirements and risks alienating some sectors of the business world, according to legal pundits.

  • January 30, 2024

    B.C. law protecting intimate images now in force

    B.C.’s legislation protecting intimate images has come into force, giving people who have had images or videos shared without their consent new avenues to get them off the internet, stop their distribution and seek compensation.

  • January 26, 2024

    Vigilance over licensees in trademark agreements

    Ensuring sufficient control over licensees is as critical as guarding against infringers when protecting trademark rights.

  • January 26, 2024

    Federal Court rules against Biogen in trademark infringement dispute with Novartis

    The Federal Court has prohibited Biogen from using a trademark for an ophthalmological drug, finding that its use of the mark would infringe Novartis’ right in a registered trademark for a drug used to treat the same medical condition.

  • January 26, 2024

    Plaintiffs seeking injunction called ‘tempest in a coffee pot’

    Business owners who believe that a former colleague has started a competing enterprise using their confidential business information or other proprietary rights sometimes look to the courts to step in and issue an injunction to stop such conduct. Injunctions are a powerful remedy but generally require compelling evidence illustrating the potential harm that would occur if the competing business is not stopped. The cost consequences of losing an injunction motion may dwarf the amount actually at stake in the dispute.

  • January 26, 2024

    Year in review: Lengthy trademark cases of 2023

    There were a number of noteworthy trademark decisions from the Federal Court in 2023, which resulted in new rulings that will have wide ranging implications for the future of comparative advertising and licensing of trademarks.

  • January 23, 2024

    Privacy Commissioner: Children’s privacy, tech issues key priorities over next three years

    The Office of the Privacy Commissioner (OPC) has announced that protecting the privacy of children and addressing the privacy impact of technological changes including artificial intelligence (AI) will be key priorities for the agency over the next three years. 

Can't find the article you're looking for? Click here to search the Intellectual Property archive.